Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

25.3%

46 terminated/withdrawn out of 182 trials

Success Rate

67.6%

-18.9% vs industry average

Late-Stage Pipeline

12%

21 trials in Phase 3/4

Results Transparency

26%

25 of 96 completed trials have results

Key Signals

16 recruiting25 with results31 terminated15 withdrawn

Enrollment Performance

Analytics

N/A
53(49.1%)
Phase 4
15(13.9%)
Phase 2
14(13.0%)
Phase 1
12(11.1%)
Early Phase 1
8(7.4%)
Phase 3
6(5.6%)
108Total
N/A(53)
Phase 4(15)
Phase 2(14)
Phase 1(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (182)

Showing 20 of 182 trials
NCT04098666Phase 2Active Not Recruiting

Metformin in Alzheimer's Dementia Prevention

Role: collaborator

NCT05656469Not ApplicableRecruiting

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Role: collaborator

NCT03463850Not ApplicableCompleted

Analysis of Bone Micro-Architecture as a Clinical Biomarker for Image-Based Fracture Risk Estimation.

Role: lead

NCT05988489Not ApplicableRecruiting

Dynamic Deconstructive Psychotherapy Versus Brief Intervention and Contact for Suicidal Adolescents and Young Adults

Role: lead

NCT00775476Phase 2Active Not Recruiting

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

Role: lead

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT05337826Not ApplicableActive Not Recruiting

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

Role: collaborator

NCT06975033Not ApplicableRecruiting

Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP

Role: collaborator

NCT06217302Phase 3Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Role: collaborator

NCT07373743Early Phase 1Not Yet Recruiting

Pharmacokinetic (PK) Study of Tafenoquine in Healthy Adults

Role: lead

NCT06611111Early Phase 1Recruiting

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

Role: lead

NCT05918393Not ApplicableCompleted

Behavioral Economics and Communication

Role: lead

NCT02164019Not ApplicableActive Not Recruiting

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Role: collaborator

NCT07380958Not ApplicableNot Yet Recruiting

Mirror Therapy as an Adjunct to Rehabilitation Following Total Knee Arthroplasty

Role: lead

NCT05929859Phase 1Recruiting

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

Role: collaborator

NCT05988515Not ApplicableRecruiting

AI-Assisted Treatment for Residual Speech Sound Disorders

Role: collaborator

NCT07220031Not Yet Recruiting

Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay

Role: lead

NCT06006637Not ApplicableRecruiting

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Role: lead

NCT06112093Phase 1Recruiting

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

Role: lead

NCT07215533Not ApplicableRecruiting

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

Role: collaborator